{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:30:51Z","timestamp":1793255451676,"version":"4.5.0"},"reference-count":10,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>We report the case of a 57\u2010year\u2010old male presenting with severe, recurrent perineal angioedema and cutaneous leukocytoclastic vasculitis, both of which manifested shortly after commencing lisdexamfetamine for attention deficit hyperactivity disorder. A positive rechallenge after an extensive workup confirmed a drug\u2010induced reaction. This case highlights lisdexamfetamine as a cause of non\u2010allergic angioedema and leukocytoclastic vasculitis, and demonstrates the diagnostic value of a medication history and rechallenge.<\/jats:p>","DOI":"10.1111\/ajd.14583","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T06:30:21Z","timestamp":1755498621000},"page":"418-421","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lisdexamfetamine\u2010Induced Angioedema and Leukocytoclastic Vasculitis: A Case Report"],"prefix":"10.1111","volume":"66","author":[{"given":"Samuel","family":"Morriss","sequence":"first","affiliation":[{"name":"Department of Dermatology The Royal Melbourne Hospital  Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Nicolopoulos","sequence":"additional","affiliation":[{"name":"Department of Dermatology The Royal Melbourne Hospital  Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Con","family":"Dolianitis","sequence":"additional","affiliation":[{"name":"Department of Dermatology The Royal Melbourne Hospital  Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,8,17]]},"reference":[{"issue":"4","key":"e_1_2_10_2_1","first-page":"291","article-title":"Genital Lymphedema Associated With Crohn's Disease","volume":"36","author":"Garny de La Rivi\u00e8re C.","year":"2015","journal-title":"La Revue de M\u00e9decine Interne"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.02025.x"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02319.x"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.01.074"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-014-0166-2"},{"key":"e_1_2_10_7_1","unstructured":"U.S. Food and Drug Administration VYVANSE (Lisdexamfetamine Dimesylate) Capsules for Oral Use CII https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/208510lbl.pdf."},{"key":"e_1_2_10_8_1","unstructured":"Therapeutic Goods Administration Extract From the Clinical Evaluation Report for Lisdexamfetamine Dimesilate 2017 https:\/\/www.tga.gov.au\/sites\/default\/files\/auspar\u2010lisdexamfetamine\u2010dimesilate\u2010180515\u2010cer.pdf."},{"issue":"8","key":"e_1_2_10_9_1","article-title":"Pathogenesis of Drug Induced Non\u2010Allergic Angioedema: A Review of Unusual Etiologies","volume":"9","author":"Kalambay J.","year":"2017","journal-title":"Cureus"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.12-RAI-0493"},{"key":"e_1_2_10_11_1","volume-title":"Adverse Drug Reaction Probability Scale (Naranjo) in Drug Induced Liver Injury","author":"LiverTox: Clinical and Research Information on Drug\u2010Induced Liver Injury","year":"2012"}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajd.14583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T23:37:54Z","timestamp":1763681874000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajd.14583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,17]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1111\/ajd.14583"],"URL":"https:\/\/doi.org\/10.1111\/ajd.14583","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,17]]},"assertion":[{"value":"2025-07-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}